Glucagon Market Report

Europe Glucagon Market Size, Status and Forecast 2014-2026

  • POSTDATE：Nov 11, 2019
  • PAGES：177
  • REPORT CODE：GMM374022
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Glucagon market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 9.7% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Glucagon Market Segmentations:

    By Player:

    • Roche Ltd

    • Amgen Inc

    • Samsung Bioepis

    • Biocon Ltd

    • Dr.Reddy's Laboratories Ltd

    • Sandoz International GmbH

    • Pfizer Inc

    • Teva Pharmaceuticals Industries Ltd

    • DrReddy's Laboratories Ltd

    • Celltrion Inc

    By Type:

    • Powder

    • Injection

    By End-User:

    • Oncology

    • Blood Disorder

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Glucagon Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Glucagon Market Size and Growth Rate of Powder from 2014 to 2026

    • 1.3.2 Europe Glucagon Market Size and Growth Rate of Injection from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Glucagon Market Size and Growth Rate of Oncology from 2014 to 2026

    • 1.4.2 Europe Glucagon Market Size and Growth Rate of Blood Disorder from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Glucagon Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Glucagon Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Glucagon Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Glucagon Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Glucagon Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Glucagon Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Glucagon Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Glucagon Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Glucagon Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Glucagon Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Glucagon Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Glucagon Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Glucagon Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Glucagon by Major Types

      • 3.4.1 Market Size and Growth Rate of Powder

      • 3.4.2 Market Size and Growth Rate of Injection

    4 Segmentation of Glucagon Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Glucagon by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Glucagon for Oncology

      • 4.4.2 Market Size and Growth Rate of Glucagon for Blood Disorder

    5 Market Analysis by Major Regions

    • 5.1 Europe Glucagon Production Analysis by Top Regions

    • 5.2 Europe Glucagon Consumption Analysis by Top Regions

    • 5.3 Europe Glucagon Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Glucagon Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Glucagon Production, Import, Consumption and Export Analysis

      • 5.3.3 France Glucagon Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Glucagon Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Glucagon Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Glucagon Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Glucagon Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Glucagon Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Glucagon Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Glucagon Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Glucagon Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Glucagon Production, Import, Consumption and Export Analysis

    6 Product Circulation of Glucagon Market among Top Countries

    • 6.1 Top 5 Export Countries in Glucagon Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Glucagon Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Glucagon Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Glucagon Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Glucagon Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Glucagon Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Glucagon Landscape Analysis

    • 7.1 Germany Glucagon Landscape Analysis by Major Types

    • 7.2 Germany Glucagon Landscape Analysis by Major End-Users

    8. UK Glucagon Landscape Analysis

    • 8.1 UK Glucagon Landscape Analysis by Major Types

    • 8.2 UK Glucagon Landscape Analysis by Major End-Users

    9. France Glucagon Landscape Analysis

    • 9.1 France Glucagon Landscape Analysis by Major Types

    • 9.2 France Glucagon Landscape Analysis by Major End-Users

    10. Italy Glucagon Landscape Analysis

    • 10.1 Italy Glucagon Landscape Analysis by Major Types

    • 10.2 Italy Glucagon Landscape Analysis by Major End-Users

    11. Spain Glucagon Landscape Analysis

    • 11.1 Spain Glucagon Landscape Analysis by Major Types

    • 11.2 Spain Glucagon Landscape Analysis by Major End-Users

    12. Poland Glucagon Landscape Analysis

    • 12.1 Poland Glucagon Landscape Analysis by Major Types

    • 12.2 Poland Glucagon Landscape Analysis by Major End-Users

    13. Russia Glucagon Landscape Analysis

    • 13.1 Russia Glucagon Landscape Analysis by Major Types

    • 13.2 Russia Glucagon Landscape Analysis by Major End-Users

    14. Switzerland Glucagon Landscape Analysis

    • 14.1 Switzerland Glucagon Landscape Analysis by Major Types

    • 14.2 Switzerland Glucagon Landscape Analysis by Major End-Users

    15. Turkey Glucagon Landscape Analysis

    • 15.1 Turkey Glucagon Landscape Analysis by Major Types

    • 15.2 Turkey Glucagon Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Glucagon Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Glucagon Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Glucagon Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Glucagon Landscape Analysis by Top Countries

      • 16.3.1 Denmark Glucagon Market Volume and Growth Rate

      • 16.3.2 Finland Glucagon Market Volume and Growth Rate

      • 16.3.3 Norway Glucagon Market Volume and Growth Rate

      • 16.3.4 Sweden Glucagon Market Volume and Growth Rate

      • 16.3.6 Iceland Glucagon Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Glucagon Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Glucagon Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Glucagon Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Glucagon Landscape Analysis by Top Countries

      • 17.3.1 Belgium Glucagon Market Volume and Growth Rate

      • 17.3.2 Netherlands Glucagon Market Volume and Growth Rate

      • 17.3.3 Luxembourg Glucagon Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Glucagon Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Glucagon Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Glucagon Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Glucagon Landscape Analysis by Top Countries

      • 18.3.1 Estonia Glucagon Market Volume and Growth Rate

      • 18.3.2 Latvia Glucagon Market Volume and Growth Rate

      • 18.3.3 Lithuania Glucagon Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Roche Ltd

      • 19.1.1 Roche Ltd Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Amgen Inc

      • 19.2.1 Amgen Inc Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Samsung Bioepis

      • 19.3.1 Samsung Bioepis Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Biocon Ltd

      • 19.4.1 Biocon Ltd Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Dr.Reddy's Laboratories Ltd

      • 19.5.1 Dr.Reddy's Laboratories Ltd Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Sandoz International GmbH

      • 19.6.1 Sandoz International GmbH Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Pfizer Inc

      • 19.7.1 Pfizer Inc Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Teva Pharmaceuticals Industries Ltd

      • 19.8.1 Teva Pharmaceuticals Industries Ltd Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 DrReddy's Laboratories Ltd

      • 19.9.1 DrReddy's Laboratories Ltd Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Celltrion Inc

      • 19.10.1 Celltrion Inc Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    The List of Tables and Figures (Totals 68 Figures and 126 Tables)

    • Figure Product Picture

    • Figure Europe Glucagon Market Size and Growth Rate of Powder from 2014 to 2026

    • Figure Europe Glucagon Market Size and Growth Rate of Injection from 2014 to 2026

    • Figure Europe Glucagon Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Europe Glucagon Market Size and Growth Rate of Blood Disorder from 2014 to 2026

    • Figure Germany Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure UK Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure France Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Glucagon Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Glucagon Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Glucagon

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Glucagon by Different Types from 2014 to 2026

    • Table Consumption Share of Glucagon by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Powder

    • Figure Market Size and Growth Rate of Injection

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Glucagon by Different End-Users from 2014 to 2026

    • Table Consumption Share of Glucagon by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Blood Disorder

    • Table Europe Glucagon Production by Major Regions

    • Table Europe Glucagon Production Share by Major Regions

    • Figure Europe Glucagon Production Share by Major Countries and Regions in 2014

    • Table Europe Glucagon Consumption by Major Regions

    • Table Europe Glucagon Consumption Share by Major Regions

    • Table Germany Glucagon Production, Import, Consumption and Export Analysis

    • Table UK Glucagon Production, Import, Consumption and Export Analysis

    • Table France Glucagon Production, Import, Consumption and Export Analysis

    • Table Italy Glucagon Production, Import, Consumption and Export Analysis

    • Table Spain Glucagon Production, Import, Consumption and Export Analysis

    • Table Poland Glucagon Production, Import, Consumption and Export Analysis

    • Table Russia Glucagon Production, Import, Consumption and Export Analysis

    • Table Switzerland Glucagon Production, Import, Consumption and Export Analysis

    • Table Turkey Glucagon Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Glucagon Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Glucagon Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Glucagon Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Glucagon Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Glucagon Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Glucagon Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Glucagon Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Glucagon Consumption by Types from 2014 to 2026

    • Table Germany Glucagon Consumption Share by Types from 2014 to 2026

    • Table Germany Glucagon Consumption by End-Users from 2014 to 2026

    • Table Germany Glucagon Consumption Share by End-Users from 2014 to 2026

    • Table UK Glucagon Consumption by Types from 2014 to 2026

    • Table UK Glucagon Consumption Share by Types from 2014 to 2026

    • Table UK Glucagon Consumption by End-Users from 2014 to 2026

    • Table UK Glucagon Consumption Share by End-Users from 2014 to 2026

    • Table France Glucagon Consumption by Types from 2014 to 2026

    • Table France Glucagon Consumption Share by Types from 2014 to 2026

    • Table France Glucagon Consumption by End-Users from 2014 to 2026

    • Table France Glucagon Consumption Share by End-Users from 2014 to 2026

    • Table Italy Glucagon Consumption by Types from 2014 to 2026

    • Table Italy Glucagon Consumption Share by Types from 2014 to 2026

    • Table Italy Glucagon Consumption by End-Users from 2014 to 2026

    • Table Italy Glucagon Consumption Share by End-Users from 2014 to 2026

    • Table Spain Glucagon Consumption by Types from 2014 to 2026

    • Table Spain Glucagon Consumption Share by Types from 2014 to 2026

    • Table Spain Glucagon Consumption by End-Users from 2014 to 2026

    • Table Spain Glucagon Consumption Share by End-Users from 2014 to 2026

    • Table Poland Glucagon Consumption by Types from 2014 to 2026

    • Table Poland Glucagon Consumption Share by Types from 2014 to 2026

    • Table Poland Glucagon Consumption by End-Users from 2014 to 2026

    • Table Poland Glucagon Consumption Share by End-Users from 2014 to 2026

    • Table Russia Glucagon Consumption by Types from 2014 to 2026

    • Table Russia Glucagon Consumption Share by Types from 2014 to 2026

    • Table Russia Glucagon Consumption by End-Users from 2014 to 2026

    • Table Russia Glucagon Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Glucagon Consumption by Types from 2014 to 2026

    • Table Switzerland Glucagon Consumption Share by Types from 2014 to 2026

    • Table Switzerland Glucagon Consumption by End-Users from 2014 to 2026

    • Table Switzerland Glucagon Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Glucagon Consumption by Types from 2014 to 2026

    • Table Turkey Glucagon Consumption Share by Types from 2014 to 2026

    • Table Turkey Glucagon Consumption by End-Users from 2014 to 2026

    • Table Turkey Glucagon Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Glucagon Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Glucagon Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Glucagon Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Glucagon Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Glucagon Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Glucagon Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Glucagon Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Glucagon Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Glucagon Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Glucagon Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Glucagon Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Glucagon Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Glucagon Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Glucagon Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Glucagon Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Glucagon Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Glucagon Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Glucagon Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Glucagon Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Glucagon Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Glucagon Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Glucagon Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Glucagon Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Glucagon Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Glucagon Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Glucagon Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Glucagon Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Glucagon Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Glucagon Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Roche Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Ltd

    • Figure Sales and Growth Rate Analysis of Roche Ltd

    • Figure Revenue and Market Share Analysis of Roche Ltd

    • Table Product and Service Introduction of Roche Ltd

    • Table Company Profile and Development Status of Amgen Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc

    • Figure Sales and Growth Rate Analysis of Amgen Inc

    • Figure Revenue and Market Share Analysis of Amgen Inc

    • Table Product and Service Introduction of Amgen Inc

    • Table Company Profile and Development Status of Samsung Bioepis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Samsung Bioepis

    • Figure Sales and Growth Rate Analysis of Samsung Bioepis

    • Figure Revenue and Market Share Analysis of Samsung Bioepis

    • Table Product and Service Introduction of Samsung Bioepis

    • Table Company Profile and Development Status of Biocon Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon Ltd

    • Figure Sales and Growth Rate Analysis of Biocon Ltd

    • Figure Revenue and Market Share Analysis of Biocon Ltd

    • Table Product and Service Introduction of Biocon Ltd

    • Table Company Profile and Development Status of Dr.Reddy's Laboratories Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr.Reddy's Laboratories Ltd

    • Figure Sales and Growth Rate Analysis of Dr.Reddy's Laboratories Ltd

    • Figure Revenue and Market Share Analysis of Dr.Reddy's Laboratories Ltd

    • Table Product and Service Introduction of Dr.Reddy's Laboratories Ltd

    • Table Company Profile and Development Status of Sandoz International GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz International GmbH

    • Figure Sales and Growth Rate Analysis of Sandoz International GmbH

    • Figure Revenue and Market Share Analysis of Sandoz International GmbH

    • Table Product and Service Introduction of Sandoz International GmbH

    • Table Company Profile and Development Status of Pfizer Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

    • Figure Sales and Growth Rate Analysis of Pfizer Inc

    • Figure Revenue and Market Share Analysis of Pfizer Inc

    • Table Product and Service Introduction of Pfizer Inc

    • Table Company Profile and Development Status of Teva Pharmaceuticals Industries Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceuticals Industries Ltd

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceuticals Industries Ltd

    • Figure Revenue and Market Share Analysis of Teva Pharmaceuticals Industries Ltd

    • Table Product and Service Introduction of Teva Pharmaceuticals Industries Ltd

    • Table Company Profile and Development Status of DrReddy's Laboratories Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of DrReddy's Laboratories Ltd

    • Figure Sales and Growth Rate Analysis of DrReddy's Laboratories Ltd

    • Figure Revenue and Market Share Analysis of DrReddy's Laboratories Ltd

    • Table Product and Service Introduction of DrReddy's Laboratories Ltd

    • Table Company Profile and Development Status of Celltrion Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion Inc

    • Figure Sales and Growth Rate Analysis of Celltrion Inc

    • Figure Revenue and Market Share Analysis of Celltrion Inc

    • Table Product and Service Introduction of Celltrion Inc

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US